The Atlantic Examines Challenges Surrounding TB Vaccine Development

The Atlantic: Toward an Effective Tuberculosis Vaccine
“…While we have vaccines to thank for the decline of global diseases like measles and smallpox, vaccination’s role in the worldwide battle against TB has been comparatively minimal. … So, what is it about a TB vaccine that’s had science stymied for over a century?…” (Shure, 9/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.